Four hundred and twenty-four patients with clinical data were included in the survival analysis and the patients with case HCC were divided into a high TMEM79 expression group and a low TMEM79 expression group according to the median critical value. This evidence concerns the gene TMEM79 and hepatocellular carcinoma.